Mr. Cohen, founding CEO of 20/20 GeneSystems has lead the company to raise over $6M in equity investments, launch two innovative detection products, procure over $7M in funding from govt & corporate sources, & forge agreements w/ several Fortune 500 companies. Previously Mr. Cohen was patent and general counsel for 2 publicly traded companies: Ventana Medical Systems & Oncor Mr. Cohen is a registed patent attorney with over 18 years experience.

Since 2001, manages company’s BioCheck product manufacturing, packaging & distribution operations. Heads up company’s finance operation and oversees 20/20′s accounting and investor relations. Jerry is an accountant with over 25 years in the financial planning & analysis of diagnostics & biotech companies. Spent 13 years at Becton-Dickenson (BD) including Financial Manager of Diagnostics Instruments Systems Div. & the Advanced Diagnostic Div.

Mr. Tunon has worked with some of the world’s largest life science suppliers. After studying biochemistry at Uppsala University, Sweden, he worked in technical support for Pharmacia (now GE Healthcare). Mr. Tunon was Business Director at Life Technologies for the downstream processing program. As Chromatography Business Manager at Bio-Rad Labs he managed the consumables program. Prior to joining 20/20 he was VP Sales & Marketing at Expression Pa

Joined 20/20 in late 2009. Educated and trained at the George Washington University Hospital in anatomic and clinical pathology. He then joined the Pathogenetics Unit of the National Cancer Institute where he was involved with development of laser capture microdissection & made contributions toward development of other technologies for molecular analysis of cancer tissue samples. He received several technology transfer awards for his efforts.